Literature DB >> 2832848

An indicator gene to demonstrate intracellular transposition of defective retroviruses.

T Heidmann1, O Heidmann, J F Nicolas.   

Abstract

An indicator gene for detection and quantitation of RNA-mediated transposition was constructed (neoRT). It was inserted into a Moloney murine leukemia provirus (Mo-MLV) deleted for the envelope gene to test for intracellular transposition of defective retroviruses [Mo-MLV(neo)RT]. NeoRT contains the selectable neo gene (which confers resistance to the drug G418), inactivated by a polyadenylylation sequence inserted between the neo promotor and coding sequence. The polyadenylylation sequence is flanked (on the antisense strand of the DNA) by a donor and an acceptor splice site so as to be removed upon passage of the provirus through an RNA intermediate. 3T3 cells transfected with the defective Mo-MLV(neo)RT provirus are sensitive to G418. After trans-complementation with Mo-MLV, viral transcripts confer resistance to G418 upon infection of test cells. In the resistant cells, the polyadenylylation sequence has been removed, as a result in most cases of precise splicing of the intronic domain. Retrotransposition of the defective Mo-MLV(neo)RT provirus was demonstrated by submitting transfected G418-sensitive clones to selection. Between 1 and 10 G418-resistant clones were obtained per 10(7) cells. Several possess additional copies, with evidence for precise removal of the intronic domain. By using target test cells in coculture experiments, extracellular intermediates of retrotransposition could not be detected.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2832848      PMCID: PMC279961          DOI: 10.1073/pnas.85.7.2219

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

1.  Mouse teratocarcinoma cells.

Authors:  H Jakob; J F Nicolas
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

2.  Revertants of mouse cells transformed by murine sarcoma virus. 3. Metastable expression of virus functions in revertants retransformed by murine sarcoma virus.

Authors:  P J Fischinger; S Nomura; N Tuttle-Fuller; K J Dunn
Journal:  Virology       Date:  1974-05       Impact factor: 3.616

3.  Rearrangement of the oncogene c-mos in mouse myeloma NSI and hybridomas.

Authors:  J B Cohen; T Unger; G Rechavi; E Canaani; D Givol
Journal:  Nature       Date:  1983 Dec 22-1984 Jan 4       Impact factor: 49.962

4.  Retrovirus-like particles containing RNA homologous to the transposable element copia in Drosophila melanogaster.

Authors:  T Shiba; K Saigo
Journal:  Nature       Date:  1983-03-10       Impact factor: 49.962

5.  Construction and applications of a highly transmissible murine retrovirus shuttle vector.

Authors:  C L Cepko; B E Roberts; R C Mulligan
Journal:  Cell       Date:  1984-07       Impact factor: 41.582

6.  A new dominant hybrid selective marker for higher eukaryotic cells.

Authors:  F Colbère-Garapin; F Horodniceanu; P Kourilsky; A C Garapin
Journal:  J Mol Biol       Date:  1981-07-25       Impact factor: 5.469

7.  Mutant immunoglobulin genes have repetitive DNA elements inserted into their intervening sequences.

Authors:  R G Hawley; M J Shulman; H Murialdo; D M Gibson; N Hozumi
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

8.  Reversion of a promoter deletion in yeast.

Authors:  S Scherer; C Mann; R W Davis
Journal:  Nature       Date:  1982-08-26       Impact factor: 49.962

9.  DNA methylation and gene expression: endogenous retroviral genome becomes infectious after molecular cloning.

Authors:  K Harbers; A Schnieke; H Stuhlmann; D Jähner; R Jaenisch
Journal:  Proc Natl Acad Sci U S A       Date:  1981-12       Impact factor: 11.205

10.  Selection for animal cells that express the Escherichia coli gene coding for xanthine-guanine phosphoribosyltransferase.

Authors:  R C Mulligan; P Berg
Journal:  Proc Natl Acad Sci U S A       Date:  1981-04       Impact factor: 11.205

View more
  50 in total

1.  Determination of L1 retrotransposition kinetics in cultured cells.

Authors:  E M Ostertag; E T Prak; R J DeBerardinis; J V Moran; H H Kazazian
Journal:  Nucleic Acids Res       Date:  2000-03-15       Impact factor: 16.971

2.  High-frequency intracellular transposition of a defective mammalian provirus detected by an in situ colorimetric assay.

Authors:  T Tchenio; T Heidmann
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

3.  Large retrotransposon derivatives: abundant, conserved but nonautonomous retroelements of barley and related genomes.

Authors:  Ruslan Kalendar; Carlos M Vicient; Ofer Peleg; Kesara Anamthawat-Jonsson; Alexander Bolshoy; Alan H Schulman
Journal:  Genetics       Date:  2004-03       Impact factor: 4.562

4.  Defective retroviruses can disperse in the human genome by intracellular transposition.

Authors:  T Tchenio; T Heidmann
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

5.  Analysis of LINE-1 Retrotransposition at the Single Nucleus Level.

Authors:  Pasano Bojang; Kenneth S Ramos
Journal:  J Vis Exp       Date:  2016-04-23       Impact factor: 1.355

Review 6.  The mammalian genome shaping activity of reverse transcriptase.

Authors:  P Nouvel
Journal:  Genetica       Date:  1994       Impact factor: 1.082

7.  LINE-like retrotransposition in Saccharomyces cerevisiae.

Authors:  Chun Dong; Russell T Poulter; Jeffrey S Han
Journal:  Genetics       Date:  2008-10-28       Impact factor: 4.562

8.  Endogenous retroviruses: Thierry Heidmann wins the 2009 Retrovirology prize.

Authors:  Ali Saib; Monsef Benkirane
Journal:  Retrovirology       Date:  2009-12-01       Impact factor: 4.602

9.  Single-step selection for Ty1 element retrotransposition.

Authors:  M J Curcio; D J Garfinkel
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-01       Impact factor: 11.205

10.  Retrotransposition of a marked Drosophila line-like I element in cells in culture.

Authors:  S Jensen; L Cavarec; O Dhellin; T Heidmann
Journal:  Nucleic Acids Res       Date:  1994-04-25       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.